Actively Recruiting

Phase Not Applicable
Age: 65Years - 75Years
All Genders
ID07193485

Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

Led by Cairo University · Updated on 2025-09-25

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying seniors with chronic obstructive Eustachian tube dysfunction, a condition causing distress and often not well managed by drugs. This trial evaluates whether adding Buteyko breathing exercises to usual care can improve symptoms. The study is randomized, comparing the effects of usual care alone versus usual care plus Buteyko breathing therapy in older adults. Participants are divided into two groups of twenty seniors each. Both groups receive usual care, which includes a budesonide nasal spray (64 micrograms once daily) and tablets containing 20 mg pseudoephedrine hydrochloride and 5 mg loratadine twice daily for 2 weeks. The experimental group also performs 30-minute Buteyko breathing exercises twice daily for 14 weeks. During the study, researchers assess participants using the Eustachian Tube Dysfunction Questionnaire after 2 weeks. Additional measurements include blood pressure, respiratory rate, pulse, and various health and mood questionnaires, as well as tympanometry results. These assessments help monitor health status and treatment effects throughout the trial period ending in October 2025.

CONDITIONS

Brief Title

Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

Who Can Participate

Age: 65Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Eustachian Tube Dysfunction (chronic obstructive form)
  • Unilateral ear affection
  • Senior patients
  • Chronic affection more than 3 months
Not Eligible

You will not qualify if you...

  • Obesity
  • Cardiac problems
  • Respiratory problems

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 14 weeks

Participants receive usual care for 2 weeks. Participants in one group also perform Buteyko breathing exercises twice daily for 14 weeks.

Daily breathing exercises twice per day for 14 weeks; usual care medication for 2 weeks

Trial Site Locations

Total: 1 location

1

Cairo University

Dokki, Giza Governorate, Egypt, 11432

Actively Recruiting

Loading map...

Research Team

A

Ali MA Ismail, lecturer

A

Ali mohamed, lecturer

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Placebo Controlled Randomised Study of Balloon Sinuplasty ...

Maxillary Sinusitis

Actively Recruiting

1 location

Efficacy of Adding Buteyko Breathing to Smoking Hygiene on E...

Tobacco Smoking

Actively Recruiting

1 location

Effect of Novel Exhalational Delivery System With Fluticason...

Eustachian Tube Dysfunction

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here